Biology of obsessive–compulsive disorder

Tuberous Sclerosis Alliance Preclinical Consortium Announces New Staff and Company Members

Retrieved on: 
Thursday, November 29, 2018
Rare diseases, Abnormal psychology, Autosomal dominant disorders, Biology, Medicine, Biology of obsessive–compulsive disorder, Genodermatoses, Intellectual disability, Tuberous sclerosis, TSC, Sclerosis, MTOR

SILVER SPRING, Md., Nov. 29, 2018 /PRNewswire/ --Today, the Tuberous Sclerosis Alliance (TS Alliance) announced a new staff member to drive its tuberous sclerosis complex (TSC) Preclinical Consortium.

Key Points: 
  • SILVER SPRING, Md., Nov. 29, 2018 /PRNewswire/ --Today, the Tuberous Sclerosis Alliance (TS Alliance) announced a new staff member to drive its tuberous sclerosis complex (TSC) Preclinical Consortium.
  • Dean Aguiar, PhD, has joined the TS Alliance as Director of Preclinical Research to strengthen the consortium's capabilities.
  • The TS Alliance finances the cost of testing compounds nominated by academic members, with data shared among all consortium members.
  • The Tuberous Sclerosis Alliance is the only US-based nonprofit dedicated to finding a cure for tuberous sclerosis complex while improving the lives of those effected.

New Immunological Results That Support Intralymphatic Treatment With Diamyd® to be Presented at the Immunology of Diabetes Society Congress

Retrieved on: 
Tuesday, October 23, 2018
Cell signaling, Chemistry, Neurochemistry, Biology of obsessive–compulsive disorder, gamma-Aminobutyric acid, Neurotransmitters, Allosteric modulator, GABA receptor, Allosteric regulation

The results are presented this week at the international conference Immunology of Diabetes Society Congress 2018 in London.

Key Points: 
  • The results are presented this week at the international conference Immunology of Diabetes Society Congress 2018 in London.
  • "The results are encouraging and strengthen previously published immunological and clinical findings," says Rosaura Casas, Associate Professor of experimental pediatric immunology at Linkping University.
  • "The most interesting finding is that intralymphatic treatment with GAD can create a specific and lasting shift in the body's immune response."
  • Exclusive licenses for GABA and positive allosteric modulators of GABA receptors for the treatment of diabetes and inflammatory diseases constitutes alongside with the diabetes vaccine Diamyd and Remygen key assets.

Dallas Texas Consultants Supports the Tuberous Sclerosis Alliance

Retrieved on: 
Thursday, May 31, 2018
Geography of Texas, Abnormal psychology, Rare diseases, Behavioral neuroscience, Biology of obsessive–compulsive disorder, Genodermatoses, Intellectual disability, Tuberous sclerosis, TSC, Dallas, Consultant, Sclerosis

DALLAS, May 31, 2018 /PRNewswire/ --Premier sales and marketing company Dallas Texas Consultants recently participated in a walk to raise funds to support the Tuberous Sclerosis Alliance , a nonprofit organization that works to fight the uncommon genetic disorder tuberous sclerosis complex (TSC), which affects more than one million people worldwide.

Key Points: 
  • DALLAS, May 31, 2018 /PRNewswire/ --Premier sales and marketing company Dallas Texas Consultants recently participated in a walk to raise funds to support the Tuberous Sclerosis Alliance , a nonprofit organization that works to fight the uncommon genetic disorder tuberous sclerosis complex (TSC), which affects more than one million people worldwide.
  • Team members from Dallas Texas Consultants raised more than $1,000 by participating in the StepForward to Cure TSC Dallas Walk, which was held at the Mary Heads Carter Pavilion in Carrollton, Texas in mid-May.
  • Headquartered in Dallas, Texas, privately owned sales and marketing firm Dallas Texas Consultants offers outsources sales solutions for premier clients across industries.
  • The trained sales professionals at Dallas Texas Consultants represent the client in face-to-face interactions with customers, effectively expanding the client's customer base.

Tuberous Sclerosis Alliance Announces New Global Partnerships in India and Thailand

Retrieved on: 
Tuesday, May 15, 2018
Abnormal psychology, Rare diseases, Medicine, Behavioral neuroscience, Biology of obsessive–compulsive disorder, Genodermatoses, Intellectual disability, Tuberous sclerosis, TSC, Sclerosis

SILVER SPRING, Md., May 15, 2018 /PRNewswire-USNewswire/ --In celebration of Tuberous Sclerosis Complex (TSC) Global Awareness Day on May 15, the Tuberous Sclerosis Alliance (TS Alliance) today announced its newest Global Alliances: the Tuberous Sclerosis Alliance ofIndia and the Tuberous Sclerosis Alliance Foundation in Thailand .

Key Points: 
  • SILVER SPRING, Md., May 15, 2018 /PRNewswire-USNewswire/ --In celebration of Tuberous Sclerosis Complex (TSC) Global Awareness Day on May 15, the Tuberous Sclerosis Alliance (TS Alliance) today announced its newest Global Alliances: the Tuberous Sclerosis Alliance ofIndia and the Tuberous Sclerosis Alliance Foundation in Thailand .
  • We look forward to working together to provide support for the TSC community in Thailand," said Nok Brenden, Co-Founder, Tuberous Sclerosis Foundation, Thailand.
  • The TS Alliance also has a formal partnerships with TS Alliance of Israel , Tuberous SclerosisCanadaSclrose Tubreuse , TS Alliance of Mexico and Hungarian Foundation for Tuberous Sclerosis .
  • "The TS Alliance is excited to add two outstanding global partners with the new organizations inIndia and Thailand," said TS Alliance President & CEOKari Luther Rosbeck.

Tuberous Sclerosis Complex Global Awareness Day Scheduled for May 15

Retrieved on: 
Monday, April 30, 2018
Rare diseases, Abnormal psychology, Autosomal dominant disorders, Autism, Biology of obsessive–compulsive disorder, Intellectual disability, Tuberous sclerosis, TSC, Behavioural sciences, Neuroscience, TSC1

SILVER SPRING, Md., April 30, 2018 /PRNewswire-USNewswire/ --OnMay 15, the Tuberous Sclerosis Alliance (TS Alliance) will join tuberous sclerosis complex (TSC) organizations around the world to observe the sixth annual TSC Global Awareness Day.

Key Points: 
  • SILVER SPRING, Md., April 30, 2018 /PRNewswire-USNewswire/ --OnMay 15, the Tuberous Sclerosis Alliance (TS Alliance) will join tuberous sclerosis complex (TSC) organizations around the world to observe the sixth annual TSC Global Awareness Day.
  • On this day, thousands of individuals and families affected by TSC will come together to increase public awareness of the rare disease and share their stories of hope for the future.
  • "One million people around the world are estimated to have TSC, with approximately 50,000 right here in this country," explainedKari Luther Rosbeck, President and CEO of the Tuberous Sclerosis Alliance.
  • TSC Global Awareness Day is sponsored internationally by Tuberous Sclerosis Complex International (TSCi), a worldwide consortium of TSC organizations of which the TS Alliance is a member.